A lab-made antibody treatment has shown encouraging results in preventing hospitalizations from covid-19, at least in some preliminary data. On Tuesday, the pharmaceutical company Eli Lilly announced that its experimental antibody treatment was found to reduce the rate of hospitalizations among people with covid-19 treated in an outpatient setting, compared…
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.